ArticleCureus2026
Laparoscopic Segmental Duodenectomy With Antrectomy as a Feasible Strategy for Proximal Non-ampullary Duodenal Cancer in Octogenarians: A Report of Two Cases.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The optimal therapeutic approach for early-stage non-ampullary duodenal cancer (NADC) remains challenging, particularly for tumors that are difficult to manage with endoscopic resection (ER) but do not strictly require highly invasive pancreaticoduodenectomy (PD). Here, we report two octogenarians with early-stage proximal NADC successfully treated with laparoscopic segmental duodenectomy with antrectomy (LSDA), a procedure that provides oncological radicality while minimizing invasiveness. An 89-year-old woman presented with a 30 mm Borrmann type 1-like tumor extending from the duodenal bulb to the pyloric ring, for which ER or laparoscopy-endoscopy cooperative surgery (LECS) was considered high risk due to tumor location and size. An 85-year-old woman had a tumor with suspected submucosal invasion (T1b) at the superior duodenal angle, and although no lymph node metastasis was evident, PD was considered excessively invasive given her age and frailty. In both cases, LSDA with selective lymph node dissection was safely performed, followed by Billroth II reconstruction. Both patients achieved R0 resection and had uneventful postoperative courses, with discharge within 14 days, and they remain recurrence-free at 58 and 35 months, respectively, with preserved nutritional status and quality of life. LSDA is a function-preserving and oncologically sound treatment option for older adults with early-stage NADC, serving as a versatile approach that bridges the gap between endoscopic treatment and PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.